ICU Medical Receives Premier Inc. Contract for the New Diana™ Hazardous Drug Compounding System with Barcode Scanning

New Six-Year Agreement Marks the First GPO Contract for ICU Medical's Breakthrough Automated Sterile Compounding System for the Accurate, Safe, and Efficient Preparation of Hazardous Drugs, Set to Debut at ASHP Midyear in Orlando, December 8-12

 ICU Medical Inc. (ICUI) today announced it has been awarded a six-year group purchasing contract from Premier Inc. for the Diana^TM hazardous drug compounding system, the world's first user-controlled, automated sterile compounding system for the accurate, safe, and efficient preparation of hazardous drugs. Effective in 2014, this is the first time the Diana system, introduced in the United States in 2012, has been on contract with a group purchasing organization. A new version of the Diana system that incorporates a barcode scanning system will be debuted at the American Society of Hospital Pharmacists (ASHP) midyear clinical meeting in Orlando, FL, December 8-12, 2013.

Patheon Inc. to be Taken Private for US$9.32 per Share in Cash

Patheon Inc. (TSX:PTI.TO) ("Patheon") today announced that it has entered into an arrangement agreement (the "Arrangement Agreement") with JLL/Delta Patheon Holdings, L.P., a limited partnership ("Newco") under which Patheon would be taken private pursuant to a court-approved plan of arrangement (the "Arrangement") under the Canada Business Corporations Act. Newco is sponsored by an entity controlled by JLL Partners, Inc. ("JLL") and Koninklijke DSM N.V. ("DSM"). Affiliates of JLL currently own 55.7% of the restricted voting shares of Patheon and all of the outstanding class I preferred shares, series D of Patheon (the "Preferred Shares").

CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing

CollabRx, Inc. (CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a multi-year, non-exclusive agreement with Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, related to medical annotation for new next-generation sequencing test services for cancer.

Under the agreement, Quest Diagnostics has the right to incorporate into clinical test reports for its next-generation sequencing cancer tests medical content, such as scientific literature, medical guidelines and published therapeutic protocols.

Hospital Physician Partners Selects athenahealth to Drive Performance Across Revenue Cycle Operations

Cloud-Based Services Will Support Collections, Patient Communications, and Business Intelligence for Providers Practicing in Approximately 100 Hospitals Across 22 States

athenahealth, Inc. (ATHN), a leading provider of cloud-based electronic health record (EHR), practice management, and care coordination services, today announced that Hospital Physician Partners (HPP), a medical management and staffing firm with approximately 100 client hospitals in 22 states, has selected athenahealth's cloud-based services to optimize medical billing and strengthen patient communications.